Global Ertapenem Market Growth 2026-2032
The global Ertapenem market size is predicted to grow from US$ 405 million in 2025 to US$ 559 million in 2032; it is expected to grow at a CAGR of 4.9% from 2026 to 2032.
Ertapenem is a long-acting, broad-spectrum carbapenem antibiotic, primarily supplied in the form of sterile powder for injection or injectable formulations, and is widely used for the treatment of complicated intra-abdominal infections, complicated urinary tract infections, and selected community-acquired infections. While maintaining strong activity against Gram-negative and anaerobic bacteria, it features a relatively low dosing frequency, making it well suited for standardized in-hospital medication management. Its upstream supply chain mainly includes pharmaceutical-grade beta-lactam intermediates, side-chain synthesis materials, excipients for sterile injectables such as fillers and stabilizers, aseptic consumables, and formulation equipment, all of which require stringent process control and sterility assurance. Downstream customers are primarily general hospitals, tertiary hospitals, and regional medical centers, with volume driven through centralized hospital procurement and reimbursement systems. Based on ex-factory pricing, global production capacity of ertapenem in 2025 is estimated at approximately 160,000 vials, with actual sales volume of around 12.69 million vials and an average global ex-factory price of about USD 32.6 per vial. Influenced by technical barriers in sterile manufacturing, strict quality system requirements, and pricing pressure from hospital tenders, leading manufacturers typically achieve gross margins in the range of 45%?60%, reflecting a market characterized by scaled production, relatively stable pricing, and resilient profitability.
From a market perspective, the hospital anti-infective segment in which ertapenem is positioned is relatively mature and highly regulated. In most regions, the market has transitioned from original-brand dominance to a multi-supplier structure, with competition centered more on quality systems, supply reliability, and hospital access capabilities rather than purely on pricing. Given its well-defined clinical role, ertapenem is typically classified under restricted or closely managed antibiotic categories, resulting in relatively stable demand patterns closely linked to hospital treatment protocols and infection profiles.
In terms of demand drivers, the ongoing need to manage complicated infections and antimicrobial resistance continues to underpin ertapenem usage. Aging patient populations, increasing use of invasive procedures, and a growing number of immunocompromised patients support sustained hospital demand for antibiotics with predictable efficacy and convenient administration. At the same time, antimicrobial stewardship policies emphasize rational and targeted use, reinforcing ertapenem's role in specific indications rather than eliminating its clinical relevance.
Looking ahead, the market is expected to evolve through structural optimization rather than broad-based expansion. Hospitals are placing greater emphasis on medication safety, batch consistency, and uninterrupted supply, which favors manufacturers with robust sterile production capabilities and established quality compliance. Meanwhile, the introduction of newer antimicrobial agents and combination therapies may limit ertapenem's use in certain settings, but its suitability for infections with lower non-fermenter risk and simplified dosing requirements ensures continued relevance in defined clinical scenarios.
Against this backdrop, both growth drivers and constraints shape the market outlook. Stricter antibiotic control policies can curb inappropriate utilization, while the high regulatory and technical thresholds of sterile manufacturing increase operational complexity and cost sensitivity. Fluctuations in upstream materials and compliance expenditures may further affect profitability. For manufacturers, long-term competitiveness in the ertapenem market will depend on maintaining regulatory compliance, cost control, and reliable supply within an increasingly disciplined hospital prescribing environment.
LP Information, Inc. (LPI) ' newest research report, the ?Ertapenem Industry Forecast? looks at past sales and reviews total world Ertapenem sales in 2025, providing a comprehensive analysis by region and market sector of projected Ertapenem sales for 2026 through 2032. With Ertapenem sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Ertapenem industry.
This Insight Report provides a comprehensive analysis of the global Ertapenem landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Ertapenem portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Ertapenem market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Ertapenem and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Ertapenem.
This report presents a comprehensive overview, market shares, and growth opportunities of Ertapenem market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Ertapenem is a long-acting, broad-spectrum carbapenem antibiotic, primarily supplied in the form of sterile powder for injection or injectable formulations, and is widely used for the treatment of complicated intra-abdominal infections, complicated urinary tract infections, and selected community-acquired infections. While maintaining strong activity against Gram-negative and anaerobic bacteria, it features a relatively low dosing frequency, making it well suited for standardized in-hospital medication management. Its upstream supply chain mainly includes pharmaceutical-grade beta-lactam intermediates, side-chain synthesis materials, excipients for sterile injectables such as fillers and stabilizers, aseptic consumables, and formulation equipment, all of which require stringent process control and sterility assurance. Downstream customers are primarily general hospitals, tertiary hospitals, and regional medical centers, with volume driven through centralized hospital procurement and reimbursement systems. Based on ex-factory pricing, global production capacity of ertapenem in 2025 is estimated at approximately 160,000 vials, with actual sales volume of around 12.69 million vials and an average global ex-factory price of about USD 32.6 per vial. Influenced by technical barriers in sterile manufacturing, strict quality system requirements, and pricing pressure from hospital tenders, leading manufacturers typically achieve gross margins in the range of 45%?60%, reflecting a market characterized by scaled production, relatively stable pricing, and resilient profitability.
From a market perspective, the hospital anti-infective segment in which ertapenem is positioned is relatively mature and highly regulated. In most regions, the market has transitioned from original-brand dominance to a multi-supplier structure, with competition centered more on quality systems, supply reliability, and hospital access capabilities rather than purely on pricing. Given its well-defined clinical role, ertapenem is typically classified under restricted or closely managed antibiotic categories, resulting in relatively stable demand patterns closely linked to hospital treatment protocols and infection profiles.
In terms of demand drivers, the ongoing need to manage complicated infections and antimicrobial resistance continues to underpin ertapenem usage. Aging patient populations, increasing use of invasive procedures, and a growing number of immunocompromised patients support sustained hospital demand for antibiotics with predictable efficacy and convenient administration. At the same time, antimicrobial stewardship policies emphasize rational and targeted use, reinforcing ertapenem's role in specific indications rather than eliminating its clinical relevance.
Looking ahead, the market is expected to evolve through structural optimization rather than broad-based expansion. Hospitals are placing greater emphasis on medication safety, batch consistency, and uninterrupted supply, which favors manufacturers with robust sterile production capabilities and established quality compliance. Meanwhile, the introduction of newer antimicrobial agents and combination therapies may limit ertapenem's use in certain settings, but its suitability for infections with lower non-fermenter risk and simplified dosing requirements ensures continued relevance in defined clinical scenarios.
Against this backdrop, both growth drivers and constraints shape the market outlook. Stricter antibiotic control policies can curb inappropriate utilization, while the high regulatory and technical thresholds of sterile manufacturing increase operational complexity and cost sensitivity. Fluctuations in upstream materials and compliance expenditures may further affect profitability. For manufacturers, long-term competitiveness in the ertapenem market will depend on maintaining regulatory compliance, cost control, and reliable supply within an increasingly disciplined hospital prescribing environment.
LP Information, Inc. (LPI) ' newest research report, the ?Ertapenem Industry Forecast? looks at past sales and reviews total world Ertapenem sales in 2025, providing a comprehensive analysis by region and market sector of projected Ertapenem sales for 2026 through 2032. With Ertapenem sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Ertapenem industry.
This Insight Report provides a comprehensive analysis of the global Ertapenem landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Ertapenem portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Ertapenem market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Ertapenem and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Ertapenem.
This report presents a comprehensive overview, market shares, and growth opportunities of Ertapenem market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Sterile Powder for Injection
- Ready-to-use or Premixed Injection
- Others
- Complicated Intra-abdominal Infections
- Complicated Urinary Tract Infections
- Others
- Online Sales
- Offline Sales
- Hospital
- Clinic
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Merck
- Aurobindo Pharma
- Endo International
- CSPC Pharmaceutical Group
- Apotex
- Fresenius
- Dr Reddy's Laboratories
- Chongqing Shenghuaxi Pharm
- What is the 10-year outlook for the global Ertapenem market?
- What factors are driving Ertapenem market growth, globally and by region?
- Which technologies are poised for the fastest growth by market and region?
- How doErtapenem market opportunities vary by end market size?
- How does Ertapenem break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Ertapenem Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Ertapenem by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Ertapenem by Country/Region, 2021, 2025 & 2032
2.2 Ertapenem Segment by Type
2.2.1 Sterile Powder for Injection
2.2.2 Ready-to-use or Premixed Injection
2.2.3 Others
2.2.4 Ertapenem Sales by Type
2.2.4.1 Global Ertapenem Sales Market Share by Type (2021-2026)
2.2.4.2 Global Ertapenem Revenue and Market Share by Type (2021-2026)
2.2.4.3 Global Ertapenem Sale Price by Type (2021-2026)
2.3 Ertapenem Segment by Clinical Indication
2.3.1 Complicated Intra-abdominal Infections
2.3.2 Complicated Urinary Tract Infections
2.3.3 Others
2.3.4 Ertapenem Sales by Clinical Indication
2.3.4.1 Global Ertapenem Sales Market Share by Clinical Indication (2021-2026)
2.3.4.2 Global Ertapenem Revenue and Market Share by Clinical Indication (2021-2026)
2.3.4.3 Global Ertapenem Sale Price by Clinical Indication (2021-2026)
2.4 Ertapenem Segment by Sale Channels
2.4.1 Online Sales
2.4.2 Offline Sales
2.4.3 Ertapenem Sales by Sale Channels
2.4.3.1 Global Ertapenem Sales Market Share by Sale Channels (2021-2026)
2.4.3.2 Global Ertapenem Revenue and Market Share by Sale Channels (2021-2026)
2.4.3.3 Global Ertapenem Sale Price by Sale Channels (2021-2026)
2.5 Ertapenem Segment by Application
2.5.1 Hospital
2.5.2 Clinic
2.5.3 Others
2.5.4 Ertapenem Sales by Application
2.5.4.1 Global Ertapenem Sale Market Share by Application (2021-2026)
2.5.4.2 Global Ertapenem Revenue and Market Share by Application (2021-2026)
2.5.4.3 Global Ertapenem Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Ertapenem Breakdown Data by Company
3.1.1 Global Ertapenem Annual Sales by Company (2021-2026)
3.1.2 Global Ertapenem Sales Market Share by Company (2021-2026)
3.2 Global Ertapenem Annual Revenue by Company (2021-2026)
3.2.1 Global Ertapenem Revenue by Company (2021-2026)
3.2.2 Global Ertapenem Revenue Market Share by Company (2021-2026)
3.3 Global Ertapenem Sale Price by Company
3.4 Key Manufacturers Ertapenem Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Ertapenem Product Location Distribution
3.4.2 Players Ertapenem Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR ERTAPENEM BY GEOGRAPHIC REGION
4.1 World Historic Ertapenem Market Size by Geographic Region (2021-2026)
4.1.1 Global Ertapenem Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Ertapenem Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Ertapenem Market Size by Country/Region (2021-2026)
4.2.1 Global Ertapenem Annual Sales by Country/Region (2021-2026)
4.2.2 Global Ertapenem Annual Revenue by Country/Region (2021-2026)
4.3 Americas Ertapenem Sales Growth
4.4 APAC Ertapenem Sales Growth
4.5 Europe Ertapenem Sales Growth
4.6 Middle East & Africa Ertapenem Sales Growth
5 AMERICAS
5.1 Americas Ertapenem Sales by Country
5.1.1 Americas Ertapenem Sales by Country (2021-2026)
5.1.2 Americas Ertapenem Revenue by Country (2021-2026)
5.2 Americas Ertapenem Sales by Type (2021-2026)
5.3 Americas Ertapenem Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Ertapenem Sales by Region
6.1.1 APAC Ertapenem Sales by Region (2021-2026)
6.1.2 APAC Ertapenem Revenue by Region (2021-2026)
6.2 APAC Ertapenem Sales by Type (2021-2026)
6.3 APAC Ertapenem Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Ertapenem by Country
7.1.1 Europe Ertapenem Sales by Country (2021-2026)
7.1.2 Europe Ertapenem Revenue by Country (2021-2026)
7.2 Europe Ertapenem Sales by Type (2021-2026)
7.3 Europe Ertapenem Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Ertapenem by Country
8.1.1 Middle East & Africa Ertapenem Sales by Country (2021-2026)
8.1.2 Middle East & Africa Ertapenem Revenue by Country (2021-2026)
8.2 Middle East & Africa Ertapenem Sales by Type (2021-2026)
8.3 Middle East & Africa Ertapenem Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Ertapenem
10.3 Manufacturing Process Analysis of Ertapenem
10.4 Industry Chain Structure of Ertapenem
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Ertapenem Distributors
11.3 Ertapenem Customer
12 WORLD FORECAST REVIEW FOR ERTAPENEM BY GEOGRAPHIC REGION
12.1 Global Ertapenem Market Size Forecast by Region
12.1.1 Global Ertapenem Forecast by Region (2027-2032)
12.1.2 Global Ertapenem Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Ertapenem Forecast by Type (2027-2032)
12.7 Global Ertapenem Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Merck
13.1.1 Merck Company Information
13.1.2 Merck Ertapenem Product Portfolios and Specifications
13.1.3 Merck Ertapenem Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Merck Main Business Overview
13.1.5 Merck Latest Developments
13.2 Aurobindo Pharma
13.2.1 Aurobindo Pharma Company Information
13.2.2 Aurobindo Pharma Ertapenem Product Portfolios and Specifications
13.2.3 Aurobindo Pharma Ertapenem Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Aurobindo Pharma Main Business Overview
13.2.5 Aurobindo Pharma Latest Developments
13.3 Endo International
13.3.1 Endo International Company Information
13.3.2 Endo International Ertapenem Product Portfolios and Specifications
13.3.3 Endo International Ertapenem Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Endo International Main Business Overview
13.3.5 Endo International Latest Developments
13.4 CSPC Pharmaceutical Group
13.4.1 CSPC Pharmaceutical Group Company Information
13.4.2 CSPC Pharmaceutical Group Ertapenem Product Portfolios and Specifications
13.4.3 CSPC Pharmaceutical Group Ertapenem Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 CSPC Pharmaceutical Group Main Business Overview
13.4.5 CSPC Pharmaceutical Group Latest Developments
13.5 Apotex
13.5.1 Apotex Company Information
13.5.2 Apotex Ertapenem Product Portfolios and Specifications
13.5.3 Apotex Ertapenem Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Apotex Main Business Overview
13.5.5 Apotex Latest Developments
13.6 Fresenius
13.6.1 Fresenius Company Information
13.6.2 Fresenius Ertapenem Product Portfolios and Specifications
13.6.3 Fresenius Ertapenem Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Fresenius Main Business Overview
13.6.5 Fresenius Latest Developments
13.7 Dr Reddy's Laboratories
13.7.1 Dr Reddy's Laboratories Company Information
13.7.2 Dr Reddy's Laboratories Ertapenem Product Portfolios and Specifications
13.7.3 Dr Reddy's Laboratories Ertapenem Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Dr Reddy's Laboratories Main Business Overview
13.7.5 Dr Reddy's Laboratories Latest Developments
13.8 Chongqing Shenghuaxi Pharm
13.8.1 Chongqing Shenghuaxi Pharm Company Information
13.8.2 Chongqing Shenghuaxi Pharm Ertapenem Product Portfolios and Specifications
13.8.3 Chongqing Shenghuaxi Pharm Ertapenem Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Chongqing Shenghuaxi Pharm Main Business Overview
13.8.5 Chongqing Shenghuaxi Pharm Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Ertapenem Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Ertapenem by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Ertapenem by Country/Region, 2021, 2025 & 2032
2.2 Ertapenem Segment by Type
2.2.1 Sterile Powder for Injection
2.2.2 Ready-to-use or Premixed Injection
2.2.3 Others
2.2.4 Ertapenem Sales by Type
2.2.4.1 Global Ertapenem Sales Market Share by Type (2021-2026)
2.2.4.2 Global Ertapenem Revenue and Market Share by Type (2021-2026)
2.2.4.3 Global Ertapenem Sale Price by Type (2021-2026)
2.3 Ertapenem Segment by Clinical Indication
2.3.1 Complicated Intra-abdominal Infections
2.3.2 Complicated Urinary Tract Infections
2.3.3 Others
2.3.4 Ertapenem Sales by Clinical Indication
2.3.4.1 Global Ertapenem Sales Market Share by Clinical Indication (2021-2026)
2.3.4.2 Global Ertapenem Revenue and Market Share by Clinical Indication (2021-2026)
2.3.4.3 Global Ertapenem Sale Price by Clinical Indication (2021-2026)
2.4 Ertapenem Segment by Sale Channels
2.4.1 Online Sales
2.4.2 Offline Sales
2.4.3 Ertapenem Sales by Sale Channels
2.4.3.1 Global Ertapenem Sales Market Share by Sale Channels (2021-2026)
2.4.3.2 Global Ertapenem Revenue and Market Share by Sale Channels (2021-2026)
2.4.3.3 Global Ertapenem Sale Price by Sale Channels (2021-2026)
2.5 Ertapenem Segment by Application
2.5.1 Hospital
2.5.2 Clinic
2.5.3 Others
2.5.4 Ertapenem Sales by Application
2.5.4.1 Global Ertapenem Sale Market Share by Application (2021-2026)
2.5.4.2 Global Ertapenem Revenue and Market Share by Application (2021-2026)
2.5.4.3 Global Ertapenem Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Ertapenem Breakdown Data by Company
3.1.1 Global Ertapenem Annual Sales by Company (2021-2026)
3.1.2 Global Ertapenem Sales Market Share by Company (2021-2026)
3.2 Global Ertapenem Annual Revenue by Company (2021-2026)
3.2.1 Global Ertapenem Revenue by Company (2021-2026)
3.2.2 Global Ertapenem Revenue Market Share by Company (2021-2026)
3.3 Global Ertapenem Sale Price by Company
3.4 Key Manufacturers Ertapenem Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Ertapenem Product Location Distribution
3.4.2 Players Ertapenem Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR ERTAPENEM BY GEOGRAPHIC REGION
4.1 World Historic Ertapenem Market Size by Geographic Region (2021-2026)
4.1.1 Global Ertapenem Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Ertapenem Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Ertapenem Market Size by Country/Region (2021-2026)
4.2.1 Global Ertapenem Annual Sales by Country/Region (2021-2026)
4.2.2 Global Ertapenem Annual Revenue by Country/Region (2021-2026)
4.3 Americas Ertapenem Sales Growth
4.4 APAC Ertapenem Sales Growth
4.5 Europe Ertapenem Sales Growth
4.6 Middle East & Africa Ertapenem Sales Growth
5 AMERICAS
5.1 Americas Ertapenem Sales by Country
5.1.1 Americas Ertapenem Sales by Country (2021-2026)
5.1.2 Americas Ertapenem Revenue by Country (2021-2026)
5.2 Americas Ertapenem Sales by Type (2021-2026)
5.3 Americas Ertapenem Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Ertapenem Sales by Region
6.1.1 APAC Ertapenem Sales by Region (2021-2026)
6.1.2 APAC Ertapenem Revenue by Region (2021-2026)
6.2 APAC Ertapenem Sales by Type (2021-2026)
6.3 APAC Ertapenem Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Ertapenem by Country
7.1.1 Europe Ertapenem Sales by Country (2021-2026)
7.1.2 Europe Ertapenem Revenue by Country (2021-2026)
7.2 Europe Ertapenem Sales by Type (2021-2026)
7.3 Europe Ertapenem Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Ertapenem by Country
8.1.1 Middle East & Africa Ertapenem Sales by Country (2021-2026)
8.1.2 Middle East & Africa Ertapenem Revenue by Country (2021-2026)
8.2 Middle East & Africa Ertapenem Sales by Type (2021-2026)
8.3 Middle East & Africa Ertapenem Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Ertapenem
10.3 Manufacturing Process Analysis of Ertapenem
10.4 Industry Chain Structure of Ertapenem
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Ertapenem Distributors
11.3 Ertapenem Customer
12 WORLD FORECAST REVIEW FOR ERTAPENEM BY GEOGRAPHIC REGION
12.1 Global Ertapenem Market Size Forecast by Region
12.1.1 Global Ertapenem Forecast by Region (2027-2032)
12.1.2 Global Ertapenem Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Ertapenem Forecast by Type (2027-2032)
12.7 Global Ertapenem Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Merck
13.1.1 Merck Company Information
13.1.2 Merck Ertapenem Product Portfolios and Specifications
13.1.3 Merck Ertapenem Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Merck Main Business Overview
13.1.5 Merck Latest Developments
13.2 Aurobindo Pharma
13.2.1 Aurobindo Pharma Company Information
13.2.2 Aurobindo Pharma Ertapenem Product Portfolios and Specifications
13.2.3 Aurobindo Pharma Ertapenem Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Aurobindo Pharma Main Business Overview
13.2.5 Aurobindo Pharma Latest Developments
13.3 Endo International
13.3.1 Endo International Company Information
13.3.2 Endo International Ertapenem Product Portfolios and Specifications
13.3.3 Endo International Ertapenem Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Endo International Main Business Overview
13.3.5 Endo International Latest Developments
13.4 CSPC Pharmaceutical Group
13.4.1 CSPC Pharmaceutical Group Company Information
13.4.2 CSPC Pharmaceutical Group Ertapenem Product Portfolios and Specifications
13.4.3 CSPC Pharmaceutical Group Ertapenem Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 CSPC Pharmaceutical Group Main Business Overview
13.4.5 CSPC Pharmaceutical Group Latest Developments
13.5 Apotex
13.5.1 Apotex Company Information
13.5.2 Apotex Ertapenem Product Portfolios and Specifications
13.5.3 Apotex Ertapenem Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Apotex Main Business Overview
13.5.5 Apotex Latest Developments
13.6 Fresenius
13.6.1 Fresenius Company Information
13.6.2 Fresenius Ertapenem Product Portfolios and Specifications
13.6.3 Fresenius Ertapenem Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Fresenius Main Business Overview
13.6.5 Fresenius Latest Developments
13.7 Dr Reddy's Laboratories
13.7.1 Dr Reddy's Laboratories Company Information
13.7.2 Dr Reddy's Laboratories Ertapenem Product Portfolios and Specifications
13.7.3 Dr Reddy's Laboratories Ertapenem Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Dr Reddy's Laboratories Main Business Overview
13.7.5 Dr Reddy's Laboratories Latest Developments
13.8 Chongqing Shenghuaxi Pharm
13.8.1 Chongqing Shenghuaxi Pharm Company Information
13.8.2 Chongqing Shenghuaxi Pharm Ertapenem Product Portfolios and Specifications
13.8.3 Chongqing Shenghuaxi Pharm Ertapenem Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Chongqing Shenghuaxi Pharm Main Business Overview
13.8.5 Chongqing Shenghuaxi Pharm Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Ertapenem Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Ertapenem Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Sterile Powder for Injection
Table 4. Major Players of Ready-to-use or Premixed Injection
Table 5. Major Players of Others
Table 6. Global Ertapenem Sales by Type (2021-2026) & (K Units)
Table 7. Global Ertapenem Sales Market Share by Type (2021-2026)
Table 8. Global Ertapenem Revenue by Type (2021-2026) & ($ million)
Table 9. Global Ertapenem Revenue Market Share by Type (2021-2026)
Table 10. Global Ertapenem Sale Price by Type (2021-2026) & (US$/Unit)
Table 11. Major Players of Complicated Intra-abdominal Infections
Table 12. Major Players of Complicated Urinary Tract Infections
Table 13. Major Players of Others
Table 14. Global Ertapenem Sales by Clinical Indication (2021-2026) & (K Units)
Table 15. Global Ertapenem Sales Market Share by Clinical Indication (2021-2026)
Table 16. Global Ertapenem Revenue by Clinical Indication (2021-2026) & ($ million)
Table 17. Global Ertapenem Revenue Market Share by Clinical Indication (2021-2026)
Table 18. Global Ertapenem Sale Price by Clinical Indication (2021-2026) & (US$/Unit)
Table 19. Major Players of Online Sales
Table 20. Major Players of Offline Sales
Table 21. Global Ertapenem Sales by Sale Channels (2021-2026) & (K Units)
Table 22. Global Ertapenem Sales Market Share by Sale Channels (2021-2026)
Table 23. Global Ertapenem Revenue by Sale Channels (2021-2026) & ($ million)
Table 24. Global Ertapenem Revenue Market Share by Sale Channels (2021-2026)
Table 25. Global Ertapenem Sale Price by Sale Channels (2021-2026) & (US$/Unit)
Table 26. Global Ertapenem Sale by Application (2021-2026) & (K Units)
Table 27. Global Ertapenem Sale Market Share by Application (2021-2026)
Table 28. Global Ertapenem Revenue by Application (2021-2026) & ($ million)
Table 29. Global Ertapenem Revenue Market Share by Application (2021-2026)
Table 30. Global Ertapenem Sale Price by Application (2021-2026) & (US$/Unit)
Table 31. Global Ertapenem Sales by Company (2021-2026) & (K Units)
Table 32. Global Ertapenem Sales Market Share by Company (2021-2026)
Table 33. Global Ertapenem Revenue by Company (2021-2026) & ($ millions)
Table 34. Global Ertapenem Revenue Market Share by Company (2021-2026)
Table 35. Global Ertapenem Sale Price by Company (2021-2026) & (US$/Unit)
Table 36. Key Manufacturers Ertapenem Producing Area Distribution and Sales Area
Table 37. Players Ertapenem Products Offered
Table 38. Ertapenem Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 39. New Products and Potential Entrants
Table 40. Market M&A Activity & Strategy
Table 41. Global Ertapenem Sales by Geographic Region (2021-2026) & (K Units)
Table 42. Global Ertapenem Sales Market Share Geographic Region (2021-2026)
Table 43. Global Ertapenem Revenue by Geographic Region (2021-2026) & ($ millions)
Table 44. Global Ertapenem Revenue Market Share by Geographic Region (2021-2026)
Table 45. Global Ertapenem Sales by Country/Region (2021-2026) & (K Units)
Table 46. Global Ertapenem Sales Market Share by Country/Region (2021-2026)
Table 47. Global Ertapenem Revenue by Country/Region (2021-2026) & ($ millions)
Table 48. Global Ertapenem Revenue Market Share by Country/Region (2021-2026)
Table 49. Americas Ertapenem Sales by Country (2021-2026) & (K Units)
Table 50. Americas Ertapenem Sales Market Share by Country (2021-2026)
Table 51. Americas Ertapenem Revenue by Country (2021-2026) & ($ millions)
Table 52. Americas Ertapenem Sales by Type (2021-2026) & (K Units)
Table 53. Americas Ertapenem Sales by Application (2021-2026) & (K Units)
Table 54. APAC Ertapenem Sales by Region (2021-2026) & (K Units)
Table 55. APAC Ertapenem Sales Market Share by Region (2021-2026)
Table 56. APAC Ertapenem Revenue by Region (2021-2026) & ($ millions)
Table 57. APAC Ertapenem Sales by Type (2021-2026) & (K Units)
Table 58. APAC Ertapenem Sales by Application (2021-2026) & (K Units)
Table 59. Europe Ertapenem Sales by Country (2021-2026) & (K Units)
Table 60. Europe Ertapenem Revenue by Country (2021-2026) & ($ millions)
Table 61. Europe Ertapenem Sales by Type (2021-2026) & (K Units)
Table 62. Europe Ertapenem Sales by Application (2021-2026) & (K Units)
Table 63. Middle East & Africa Ertapenem Sales by Country (2021-2026) & (K Units)
Table 64. Middle East & Africa Ertapenem Revenue Market Share by Country (2021-2026)
Table 65. Middle East & Africa Ertapenem Sales by Type (2021-2026) & (K Units)
Table 66. Middle East & Africa Ertapenem Sales by Application (2021-2026) & (K Units)
Table 67. Key Market Drivers & Growth Opportunities of Ertapenem
Table 68. Key Market Challenges & Risks of Ertapenem
Table 69. Key Industry Trends of Ertapenem
Table 70. Ertapenem Raw Material
Table 71. Key Suppliers of Raw Materials
Table 72. Ertapenem Distributors List
Table 73. Ertapenem Customer List
Table 74. Global Ertapenem Sales Forecast by Region (2027-2032) & (K Units)
Table 75. Global Ertapenem Revenue Forecast by Region (2027-2032) & ($ millions)
Table 76. Americas Ertapenem Sales Forecast by Country (2027-2032) & (K Units)
Table 77. Americas Ertapenem Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 78. APAC Ertapenem Sales Forecast by Region (2027-2032) & (K Units)
Table 79. APAC Ertapenem Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 80. Europe Ertapenem Sales Forecast by Country (2027-2032) & (K Units)
Table 81. Europe Ertapenem Revenue Forecast by Country (2027-2032) & ($ millions)
Table 82. Middle East & Africa Ertapenem Sales Forecast by Country (2027-2032) & (K Units)
Table 83. Middle East & Africa Ertapenem Revenue Forecast by Country (2027-2032) & ($ millions)
Table 84. Global Ertapenem Sales Forecast by Type (2027-2032) & (K Units)
Table 85. Global Ertapenem Revenue Forecast by Type (2027-2032) & ($ millions)
Table 86. Global Ertapenem Sales Forecast by Application (2027-2032) & (K Units)
Table 87. Global Ertapenem Revenue Forecast by Application (2027-2032) & ($ millions)
Table 88. Merck Basic Information, Ertapenem Manufacturing Base, Sales Area and Its Competitors
Table 89. Merck Ertapenem Product Portfolios and Specifications
Table 90. Merck Ertapenem Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 91. Merck Main Business
Table 92. Merck Latest Developments
Table 93. Aurobindo Pharma Basic Information, Ertapenem Manufacturing Base, Sales Area and Its Competitors
Table 94. Aurobindo Pharma Ertapenem Product Portfolios and Specifications
Table 95. Aurobindo Pharma Ertapenem Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 96. Aurobindo Pharma Main Business
Table 97. Aurobindo Pharma Latest Developments
Table 98. Endo International Basic Information, Ertapenem Manufacturing Base, Sales Area and Its Competitors
Table 99. Endo International Ertapenem Product Portfolios and Specifications
Table 100. Endo International Ertapenem Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 101. Endo International Main Business
Table 102. Endo International Latest Developments
Table 103. CSPC Pharmaceutical Group Basic Information, Ertapenem Manufacturing Base, Sales Area and Its Competitors
Table 104. CSPC Pharmaceutical Group Ertapenem Product Portfolios and Specifications
Table 105. CSPC Pharmaceutical Group Ertapenem Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 106. CSPC Pharmaceutical Group Main Business
Table 107. CSPC Pharmaceutical Group Latest Developments
Table 108. Apotex Basic Information, Ertapenem Manufacturing Base, Sales Area and Its Competitors
Table 109. Apotex Ertapenem Product Portfolios and Specifications
Table 110. Apotex Ertapenem Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 111. Apotex Main Business
Table 112. Apotex Latest Developments
Table 113. Fresenius Basic Information, Ertapenem Manufacturing Base, Sales Area and Its Competitors
Table 114. Fresenius Ertapenem Product Portfolios and Specifications
Table 115. Fresenius Ertapenem Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 116. Fresenius Main Business
Table 117. Fresenius Latest Developments
Table 118. Dr Reddy's Laboratories Basic Information, Ertapenem Manufacturing Base, Sales Area and Its Competitors
Table 119. Dr Reddy's Laboratories Ertapenem Product Portfolios and Specifications
Table 120. Dr Reddy's Laboratories Ertapenem Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 121. Dr Reddy's Laboratories Main Business
Table 122. Dr Reddy's Laboratories Latest Developments
Table 123. Chongqing Shenghuaxi Pharm Basic Information, Ertapenem Manufacturing Base, Sales Area and Its Competitors
Table 124. Chongqing Shenghuaxi Pharm Ertapenem Product Portfolios and Specifications
Table 125. Chongqing Shenghuaxi Pharm Ertapenem Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 126. Chongqing Shenghuaxi Pharm Main Business
Table 127. Chongqing Shenghuaxi Pharm Latest Developments
Table 1. Ertapenem Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Ertapenem Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Sterile Powder for Injection
Table 4. Major Players of Ready-to-use or Premixed Injection
Table 5. Major Players of Others
Table 6. Global Ertapenem Sales by Type (2021-2026) & (K Units)
Table 7. Global Ertapenem Sales Market Share by Type (2021-2026)
Table 8. Global Ertapenem Revenue by Type (2021-2026) & ($ million)
Table 9. Global Ertapenem Revenue Market Share by Type (2021-2026)
Table 10. Global Ertapenem Sale Price by Type (2021-2026) & (US$/Unit)
Table 11. Major Players of Complicated Intra-abdominal Infections
Table 12. Major Players of Complicated Urinary Tract Infections
Table 13. Major Players of Others
Table 14. Global Ertapenem Sales by Clinical Indication (2021-2026) & (K Units)
Table 15. Global Ertapenem Sales Market Share by Clinical Indication (2021-2026)
Table 16. Global Ertapenem Revenue by Clinical Indication (2021-2026) & ($ million)
Table 17. Global Ertapenem Revenue Market Share by Clinical Indication (2021-2026)
Table 18. Global Ertapenem Sale Price by Clinical Indication (2021-2026) & (US$/Unit)
Table 19. Major Players of Online Sales
Table 20. Major Players of Offline Sales
Table 21. Global Ertapenem Sales by Sale Channels (2021-2026) & (K Units)
Table 22. Global Ertapenem Sales Market Share by Sale Channels (2021-2026)
Table 23. Global Ertapenem Revenue by Sale Channels (2021-2026) & ($ million)
Table 24. Global Ertapenem Revenue Market Share by Sale Channels (2021-2026)
Table 25. Global Ertapenem Sale Price by Sale Channels (2021-2026) & (US$/Unit)
Table 26. Global Ertapenem Sale by Application (2021-2026) & (K Units)
Table 27. Global Ertapenem Sale Market Share by Application (2021-2026)
Table 28. Global Ertapenem Revenue by Application (2021-2026) & ($ million)
Table 29. Global Ertapenem Revenue Market Share by Application (2021-2026)
Table 30. Global Ertapenem Sale Price by Application (2021-2026) & (US$/Unit)
Table 31. Global Ertapenem Sales by Company (2021-2026) & (K Units)
Table 32. Global Ertapenem Sales Market Share by Company (2021-2026)
Table 33. Global Ertapenem Revenue by Company (2021-2026) & ($ millions)
Table 34. Global Ertapenem Revenue Market Share by Company (2021-2026)
Table 35. Global Ertapenem Sale Price by Company (2021-2026) & (US$/Unit)
Table 36. Key Manufacturers Ertapenem Producing Area Distribution and Sales Area
Table 37. Players Ertapenem Products Offered
Table 38. Ertapenem Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 39. New Products and Potential Entrants
Table 40. Market M&A Activity & Strategy
Table 41. Global Ertapenem Sales by Geographic Region (2021-2026) & (K Units)
Table 42. Global Ertapenem Sales Market Share Geographic Region (2021-2026)
Table 43. Global Ertapenem Revenue by Geographic Region (2021-2026) & ($ millions)
Table 44. Global Ertapenem Revenue Market Share by Geographic Region (2021-2026)
Table 45. Global Ertapenem Sales by Country/Region (2021-2026) & (K Units)
Table 46. Global Ertapenem Sales Market Share by Country/Region (2021-2026)
Table 47. Global Ertapenem Revenue by Country/Region (2021-2026) & ($ millions)
Table 48. Global Ertapenem Revenue Market Share by Country/Region (2021-2026)
Table 49. Americas Ertapenem Sales by Country (2021-2026) & (K Units)
Table 50. Americas Ertapenem Sales Market Share by Country (2021-2026)
Table 51. Americas Ertapenem Revenue by Country (2021-2026) & ($ millions)
Table 52. Americas Ertapenem Sales by Type (2021-2026) & (K Units)
Table 53. Americas Ertapenem Sales by Application (2021-2026) & (K Units)
Table 54. APAC Ertapenem Sales by Region (2021-2026) & (K Units)
Table 55. APAC Ertapenem Sales Market Share by Region (2021-2026)
Table 56. APAC Ertapenem Revenue by Region (2021-2026) & ($ millions)
Table 57. APAC Ertapenem Sales by Type (2021-2026) & (K Units)
Table 58. APAC Ertapenem Sales by Application (2021-2026) & (K Units)
Table 59. Europe Ertapenem Sales by Country (2021-2026) & (K Units)
Table 60. Europe Ertapenem Revenue by Country (2021-2026) & ($ millions)
Table 61. Europe Ertapenem Sales by Type (2021-2026) & (K Units)
Table 62. Europe Ertapenem Sales by Application (2021-2026) & (K Units)
Table 63. Middle East & Africa Ertapenem Sales by Country (2021-2026) & (K Units)
Table 64. Middle East & Africa Ertapenem Revenue Market Share by Country (2021-2026)
Table 65. Middle East & Africa Ertapenem Sales by Type (2021-2026) & (K Units)
Table 66. Middle East & Africa Ertapenem Sales by Application (2021-2026) & (K Units)
Table 67. Key Market Drivers & Growth Opportunities of Ertapenem
Table 68. Key Market Challenges & Risks of Ertapenem
Table 69. Key Industry Trends of Ertapenem
Table 70. Ertapenem Raw Material
Table 71. Key Suppliers of Raw Materials
Table 72. Ertapenem Distributors List
Table 73. Ertapenem Customer List
Table 74. Global Ertapenem Sales Forecast by Region (2027-2032) & (K Units)
Table 75. Global Ertapenem Revenue Forecast by Region (2027-2032) & ($ millions)
Table 76. Americas Ertapenem Sales Forecast by Country (2027-2032) & (K Units)
Table 77. Americas Ertapenem Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 78. APAC Ertapenem Sales Forecast by Region (2027-2032) & (K Units)
Table 79. APAC Ertapenem Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 80. Europe Ertapenem Sales Forecast by Country (2027-2032) & (K Units)
Table 81. Europe Ertapenem Revenue Forecast by Country (2027-2032) & ($ millions)
Table 82. Middle East & Africa Ertapenem Sales Forecast by Country (2027-2032) & (K Units)
Table 83. Middle East & Africa Ertapenem Revenue Forecast by Country (2027-2032) & ($ millions)
Table 84. Global Ertapenem Sales Forecast by Type (2027-2032) & (K Units)
Table 85. Global Ertapenem Revenue Forecast by Type (2027-2032) & ($ millions)
Table 86. Global Ertapenem Sales Forecast by Application (2027-2032) & (K Units)
Table 87. Global Ertapenem Revenue Forecast by Application (2027-2032) & ($ millions)
Table 88. Merck Basic Information, Ertapenem Manufacturing Base, Sales Area and Its Competitors
Table 89. Merck Ertapenem Product Portfolios and Specifications
Table 90. Merck Ertapenem Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 91. Merck Main Business
Table 92. Merck Latest Developments
Table 93. Aurobindo Pharma Basic Information, Ertapenem Manufacturing Base, Sales Area and Its Competitors
Table 94. Aurobindo Pharma Ertapenem Product Portfolios and Specifications
Table 95. Aurobindo Pharma Ertapenem Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 96. Aurobindo Pharma Main Business
Table 97. Aurobindo Pharma Latest Developments
Table 98. Endo International Basic Information, Ertapenem Manufacturing Base, Sales Area and Its Competitors
Table 99. Endo International Ertapenem Product Portfolios and Specifications
Table 100. Endo International Ertapenem Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 101. Endo International Main Business
Table 102. Endo International Latest Developments
Table 103. CSPC Pharmaceutical Group Basic Information, Ertapenem Manufacturing Base, Sales Area and Its Competitors
Table 104. CSPC Pharmaceutical Group Ertapenem Product Portfolios and Specifications
Table 105. CSPC Pharmaceutical Group Ertapenem Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 106. CSPC Pharmaceutical Group Main Business
Table 107. CSPC Pharmaceutical Group Latest Developments
Table 108. Apotex Basic Information, Ertapenem Manufacturing Base, Sales Area and Its Competitors
Table 109. Apotex Ertapenem Product Portfolios and Specifications
Table 110. Apotex Ertapenem Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 111. Apotex Main Business
Table 112. Apotex Latest Developments
Table 113. Fresenius Basic Information, Ertapenem Manufacturing Base, Sales Area and Its Competitors
Table 114. Fresenius Ertapenem Product Portfolios and Specifications
Table 115. Fresenius Ertapenem Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 116. Fresenius Main Business
Table 117. Fresenius Latest Developments
Table 118. Dr Reddy's Laboratories Basic Information, Ertapenem Manufacturing Base, Sales Area and Its Competitors
Table 119. Dr Reddy's Laboratories Ertapenem Product Portfolios and Specifications
Table 120. Dr Reddy's Laboratories Ertapenem Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 121. Dr Reddy's Laboratories Main Business
Table 122. Dr Reddy's Laboratories Latest Developments
Table 123. Chongqing Shenghuaxi Pharm Basic Information, Ertapenem Manufacturing Base, Sales Area and Its Competitors
Table 124. Chongqing Shenghuaxi Pharm Ertapenem Product Portfolios and Specifications
Table 125. Chongqing Shenghuaxi Pharm Ertapenem Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 126. Chongqing Shenghuaxi Pharm Main Business
Table 127. Chongqing Shenghuaxi Pharm Latest Developments
LIST OF FIGURES
Figure 1. Picture of Ertapenem
Figure 2. Ertapenem Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Ertapenem Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Ertapenem Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Ertapenem Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Ertapenem Sales Market Share by Country/Region (2025)
Figure 10. Ertapenem Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Sterile Powder for Injection
Figure 12. Product Picture of Ready-to-use or Premixed Injection
Figure 13. Product Picture of Others
Figure 14. Global Ertapenem Sales Market Share by Type in 2026
Figure 15. Global Ertapenem Revenue Market Share by Type (2021-2026)
Figure 16. Product Picture of Complicated Intra-abdominal Infections
Figure 17. Product Picture of Complicated Urinary Tract Infections
Figure 18. Product Picture of Others
Figure 19. Global Ertapenem Sales Market Share by Clinical Indication in 2026
Figure 20. Global Ertapenem Revenue Market Share by Clinical Indication (2021-2026)
Figure 21. Product Picture of Online Sales
Figure 22. Product Picture of Offline Sales
Figure 23. Global Ertapenem Sales Market Share by Sale Channels in 2026
Figure 24. Global Ertapenem Revenue Market Share by Sale Channels (2021-2026)
Figure 25. Ertapenem Consumed in Hospital
Figure 26. Global Ertapenem Market: Hospital (2021-2026) & (K Units)
Figure 27. Ertapenem Consumed in Clinic
Figure 28. Global Ertapenem Market: Clinic (2021-2026) & (K Units)
Figure 29. Ertapenem Consumed in Others
Figure 30. Global Ertapenem Market: Others (2021-2026) & (K Units)
Figure 31. Global Ertapenem Sale Market Share by Application (2025)
Figure 32. Global Ertapenem Revenue Market Share by Application in 2026
Figure 33. Ertapenem Sales by Company in 2026 (K Units)
Figure 34. Global Ertapenem Sales Market Share by Company in 2026
Figure 35. Ertapenem Revenue by Company in 2026 ($ millions)
Figure 36. Global Ertapenem Revenue Market Share by Company in 2026
Figure 37. Global Ertapenem Sales Market Share by Geographic Region (2021-2026)
Figure 38. Global Ertapenem Revenue Market Share by Geographic Region in 2026
Figure 39. Americas Ertapenem Sales 2021-2026 (K Units)
Figure 40. Americas Ertapenem Revenue 2021-2026 ($ millions)
Figure 41. APAC Ertapenem Sales 2021-2026 (K Units)
Figure 42. APAC Ertapenem Revenue 2021-2026 ($ millions)
Figure 43. Europe Ertapenem Sales 2021-2026 (K Units)
Figure 44. Europe Ertapenem Revenue 2021-2026 ($ millions)
Figure 45. Middle East & Africa Ertapenem Sales 2021-2026 (K Units)
Figure 46. Middle East & Africa Ertapenem Revenue 2021-2026 ($ millions)
Figure 47. Americas Ertapenem Sales Market Share by Country in 2026
Figure 48. Americas Ertapenem Revenue Market Share by Country (2021-2026)
Figure 49. Americas Ertapenem Sales Market Share by Type (2021-2026)
Figure 50. Americas Ertapenem Sales Market Share by Application (2021-2026)
Figure 51. United States Ertapenem Revenue Growth 2021-2026 ($ millions)
Figure 52. Canada Ertapenem Revenue Growth 2021-2026 ($ millions)
Figure 53. Mexico Ertapenem Revenue Growth 2021-2026 ($ millions)
Figure 54. Brazil Ertapenem Revenue Growth 2021-2026 ($ millions)
Figure 55. APAC Ertapenem Sales Market Share by Region in 2026
Figure 56. APAC Ertapenem Revenue Market Share by Region (2021-2026)
Figure 57. APAC Ertapenem Sales Market Share by Type (2021-2026)
Figure 58. APAC Ertapenem Sales Market Share by Application (2021-2026)
Figure 59. China Ertapenem Revenue Growth 2021-2026 ($ millions)
Figure 60. Japan Ertapenem Revenue Growth 2021-2026 ($ millions)
Figure 61. South Korea Ertapenem Revenue Growth 2021-2026 ($ millions)
Figure 62. Southeast Asia Ertapenem Revenue Growth 2021-2026 ($ millions)
Figure 63. India Ertapenem Revenue Growth 2021-2026 ($ millions)
Figure 64. Australia Ertapenem Revenue Growth 2021-2026 ($ millions)
Figure 65. China Taiwan Ertapenem Revenue Growth 2021-2026 ($ millions)
Figure 66. Europe Ertapenem Sales Market Share by Country in 2026
Figure 67. Europe Ertapenem Revenue Market Share by Country (2021-2026)
Figure 68. Europe Ertapenem Sales Market Share by Type (2021-2026)
Figure 69. Europe Ertapenem Sales Market Share by Application (2021-2026)
Figure 70. Germany Ertapenem Revenue Growth 2021-2026 ($ millions)
Figure 71. France Ertapenem Revenue Growth 2021-2026 ($ millions)
Figure 72. UK Ertapenem Revenue Growth 2021-2026 ($ millions)
Figure 73. Italy Ertapenem Revenue Growth 2021-2026 ($ millions)
Figure 74. Russia Ertapenem Revenue Growth 2021-2026 ($ millions)
Figure 75. Middle East & Africa Ertapenem Sales Market Share by Country (2021-2026)
Figure 76. Middle East & Africa Ertapenem Sales Market Share by Type (2021-2026)
Figure 77. Middle East & Africa Ertapenem Sales Market Share by Application (2021-2026)
Figure 78. Egypt Ertapenem Revenue Growth 2021-2026 ($ millions)
Figure 79. South Africa Ertapenem Revenue Growth 2021-2026 ($ millions)
Figure 80. Israel Ertapenem Revenue Growth 2021-2026 ($ millions)
Figure 81. Turkey Ertapenem Revenue Growth 2021-2026 ($ millions)
Figure 82. GCC Countries Ertapenem Revenue Growth 2021-2026 ($ millions)
Figure 83. Manufacturing Cost Structure Analysis of Ertapenem in 2026
Figure 84. Manufacturing Process Analysis of Ertapenem
Figure 85. Industry Chain Structure of Ertapenem
Figure 86. Channels of Distribution
Figure 87. Global Ertapenem Sales Market Forecast by Region (2027-2032)
Figure 88. Global Ertapenem Revenue Market Share Forecast by Region (2027-2032)
Figure 89. Global Ertapenem Sales Market Share Forecast by Type (2027-2032)
Figure 90. Global Ertapenem Revenue Market Share Forecast by Type (2027-2032)
Figure 91. Global Ertapenem Sales Market Share Forecast by Application (2027-2032)
Figure 92. Global Ertapenem Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Ertapenem
Figure 2. Ertapenem Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Ertapenem Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Ertapenem Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Ertapenem Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Ertapenem Sales Market Share by Country/Region (2025)
Figure 10. Ertapenem Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Sterile Powder for Injection
Figure 12. Product Picture of Ready-to-use or Premixed Injection
Figure 13. Product Picture of Others
Figure 14. Global Ertapenem Sales Market Share by Type in 2026
Figure 15. Global Ertapenem Revenue Market Share by Type (2021-2026)
Figure 16. Product Picture of Complicated Intra-abdominal Infections
Figure 17. Product Picture of Complicated Urinary Tract Infections
Figure 18. Product Picture of Others
Figure 19. Global Ertapenem Sales Market Share by Clinical Indication in 2026
Figure 20. Global Ertapenem Revenue Market Share by Clinical Indication (2021-2026)
Figure 21. Product Picture of Online Sales
Figure 22. Product Picture of Offline Sales
Figure 23. Global Ertapenem Sales Market Share by Sale Channels in 2026
Figure 24. Global Ertapenem Revenue Market Share by Sale Channels (2021-2026)
Figure 25. Ertapenem Consumed in Hospital
Figure 26. Global Ertapenem Market: Hospital (2021-2026) & (K Units)
Figure 27. Ertapenem Consumed in Clinic
Figure 28. Global Ertapenem Market: Clinic (2021-2026) & (K Units)
Figure 29. Ertapenem Consumed in Others
Figure 30. Global Ertapenem Market: Others (2021-2026) & (K Units)
Figure 31. Global Ertapenem Sale Market Share by Application (2025)
Figure 32. Global Ertapenem Revenue Market Share by Application in 2026
Figure 33. Ertapenem Sales by Company in 2026 (K Units)
Figure 34. Global Ertapenem Sales Market Share by Company in 2026
Figure 35. Ertapenem Revenue by Company in 2026 ($ millions)
Figure 36. Global Ertapenem Revenue Market Share by Company in 2026
Figure 37. Global Ertapenem Sales Market Share by Geographic Region (2021-2026)
Figure 38. Global Ertapenem Revenue Market Share by Geographic Region in 2026
Figure 39. Americas Ertapenem Sales 2021-2026 (K Units)
Figure 40. Americas Ertapenem Revenue 2021-2026 ($ millions)
Figure 41. APAC Ertapenem Sales 2021-2026 (K Units)
Figure 42. APAC Ertapenem Revenue 2021-2026 ($ millions)
Figure 43. Europe Ertapenem Sales 2021-2026 (K Units)
Figure 44. Europe Ertapenem Revenue 2021-2026 ($ millions)
Figure 45. Middle East & Africa Ertapenem Sales 2021-2026 (K Units)
Figure 46. Middle East & Africa Ertapenem Revenue 2021-2026 ($ millions)
Figure 47. Americas Ertapenem Sales Market Share by Country in 2026
Figure 48. Americas Ertapenem Revenue Market Share by Country (2021-2026)
Figure 49. Americas Ertapenem Sales Market Share by Type (2021-2026)
Figure 50. Americas Ertapenem Sales Market Share by Application (2021-2026)
Figure 51. United States Ertapenem Revenue Growth 2021-2026 ($ millions)
Figure 52. Canada Ertapenem Revenue Growth 2021-2026 ($ millions)
Figure 53. Mexico Ertapenem Revenue Growth 2021-2026 ($ millions)
Figure 54. Brazil Ertapenem Revenue Growth 2021-2026 ($ millions)
Figure 55. APAC Ertapenem Sales Market Share by Region in 2026
Figure 56. APAC Ertapenem Revenue Market Share by Region (2021-2026)
Figure 57. APAC Ertapenem Sales Market Share by Type (2021-2026)
Figure 58. APAC Ertapenem Sales Market Share by Application (2021-2026)
Figure 59. China Ertapenem Revenue Growth 2021-2026 ($ millions)
Figure 60. Japan Ertapenem Revenue Growth 2021-2026 ($ millions)
Figure 61. South Korea Ertapenem Revenue Growth 2021-2026 ($ millions)
Figure 62. Southeast Asia Ertapenem Revenue Growth 2021-2026 ($ millions)
Figure 63. India Ertapenem Revenue Growth 2021-2026 ($ millions)
Figure 64. Australia Ertapenem Revenue Growth 2021-2026 ($ millions)
Figure 65. China Taiwan Ertapenem Revenue Growth 2021-2026 ($ millions)
Figure 66. Europe Ertapenem Sales Market Share by Country in 2026
Figure 67. Europe Ertapenem Revenue Market Share by Country (2021-2026)
Figure 68. Europe Ertapenem Sales Market Share by Type (2021-2026)
Figure 69. Europe Ertapenem Sales Market Share by Application (2021-2026)
Figure 70. Germany Ertapenem Revenue Growth 2021-2026 ($ millions)
Figure 71. France Ertapenem Revenue Growth 2021-2026 ($ millions)
Figure 72. UK Ertapenem Revenue Growth 2021-2026 ($ millions)
Figure 73. Italy Ertapenem Revenue Growth 2021-2026 ($ millions)
Figure 74. Russia Ertapenem Revenue Growth 2021-2026 ($ millions)
Figure 75. Middle East & Africa Ertapenem Sales Market Share by Country (2021-2026)
Figure 76. Middle East & Africa Ertapenem Sales Market Share by Type (2021-2026)
Figure 77. Middle East & Africa Ertapenem Sales Market Share by Application (2021-2026)
Figure 78. Egypt Ertapenem Revenue Growth 2021-2026 ($ millions)
Figure 79. South Africa Ertapenem Revenue Growth 2021-2026 ($ millions)
Figure 80. Israel Ertapenem Revenue Growth 2021-2026 ($ millions)
Figure 81. Turkey Ertapenem Revenue Growth 2021-2026 ($ millions)
Figure 82. GCC Countries Ertapenem Revenue Growth 2021-2026 ($ millions)
Figure 83. Manufacturing Cost Structure Analysis of Ertapenem in 2026
Figure 84. Manufacturing Process Analysis of Ertapenem
Figure 85. Industry Chain Structure of Ertapenem
Figure 86. Channels of Distribution
Figure 87. Global Ertapenem Sales Market Forecast by Region (2027-2032)
Figure 88. Global Ertapenem Revenue Market Share Forecast by Region (2027-2032)
Figure 89. Global Ertapenem Sales Market Share Forecast by Type (2027-2032)
Figure 90. Global Ertapenem Revenue Market Share Forecast by Type (2027-2032)
Figure 91. Global Ertapenem Sales Market Share Forecast by Application (2027-2032)
Figure 92. Global Ertapenem Revenue Market Share Forecast by Application (2027-2032)
